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1. Supplementary Tables 
Supplementary Table 1. Sequences of SepRS mutants identified from the SepRS(AC6) library. 
Sequences RS1-RS14 are EF-Sep dependent and RS15-R17 are EF-Sep independent. 
 
 E412 E414 K417 P495 I496 F529 
RS1 A G S P I H 
RS2 P F K M W S 
RS3 P F R M W S 
RS4 P F R K W S 
RS5 P P W A A E 
RS6 P V R T W S 
RS7 A T G H W I 
RS8 P P K P W H 
RS9 K F R C A F 
RS10 P F K G W Q 
RS11 N T F A W T 
RS12 T V K M K R 
RS13 P K L G W Q 
RS14 S P K E W K 
RS15 P P V K W H 
RS16 P P V M W S 
RS17 P P K N F W 
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Supplementary Table 3. Primer sequences used to generate a set of F529 mutant templates for 
the SepRS(A6) library. 
 
F529 mutated to: Primer Sequence: 
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Supplementary Table 4. “small intelligent” oligo sets to used on the F529X template plasmids 
to generate the the SepRS(A6) library. The ratio the primers were mixed in to get unbiased 
coverage is shown in the third column.  M= A,C; K= G,T; B= C,G,T; D= A,G,T; H= A,C,T; V= 
A,C,G; N= A,C,G,T. 
 
 
SepRS Library primer set 1 E412, E414 Mix ratio 




































SepRS P1 AGTGGTCTCACCTTCTKBCTTCCAGAAGATGTTGAT 6 



































SepRS Library primer set 2 K417 
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 SepRS Library primer set 3 P495, I496  




























































































2. Supplementary Figures 
 
 
Supplementary Figure 1. Comparing the activity of previously reported phosphoserine 
incorporation systems1, 2 and our selected EF-Sep dependent and EF-Sep independent 
system.   The data show the chloramphenicol resistance mediated by read-through of an amber 
stop codon at position 112 in a chloramphenicol acetyl transferase gene, the exact position used 
to characterize systems for phosphoserine incorporation in previous work1, 2. The previously 
reported SepRS91 is labelled 9* in this figure to  avoid confusion with SepRS variants selected in 
our work.  EF-Sep2 and EF-Sep211 are previously described variants of EF-Tu.  In our hands, 
SepRS 9* and EF-Sep21 were no more active than SepRS and EF-Sep. EF-Sep21 provided no 
advantage over EF-Sep when combined with SepRS, SepRS 9* or our evolved SepRS (2).  
SepRS 9* provided no advantage over SepRS when combined with either EF-Sep or EF-Sep21.  
The EF-Sep/SepRS (2) /pSer tRNA (B4)CUA system discovered in this work is more than 18 
times more active than the previously reported systems1, 2, while the EF-Sep independent system 
discovered in this work, SepRS (17) /pSer tRNA (B2)CUA, is more than 8 times more active than 
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Supplementary Figure 2.  Full gels and blots for cropped images. a. Corresponds to Figure 
1c. b. Corresponds to Figure 2c. c. Corresponds to Figure 3b. d. Corresponds to Figure 3d. e. 
Corresponds to Figure 4a. f. Corresponds to Figure 4e (top panel). g. Corresponds to Figure 4e 
(middle panel). h. Corresponds to Figure 4e (bottom panel). i. Corresponds to Figure 5a. j. 
Corresponds to Figure 6c. k. Corresponds to Figure 6d (top panel). l. Corresponds to Figure 6d 









Supplementary Figure 3.  ESI-MS from the expressions shown in Figure 1.  Electrospray 
ionization mass spectrometry of purified Myoglobin(127pSer)-His6 demonstrates the quantitative 
incorporation of phosphoserine using SepRS, EF-Sep and the indicated tRNA. In all cases phosphoserine 
incorporation is quantitative.  The found mass was 18407 Da for all samples, the calculated mass is 18407 
Da). 
 




Supplementary Figure 4. ESI-MS from the expressions shown in Figure 2.  Electrospray 
ionization mass spectrometry of purified Myoglobin(127pSer)-His6 demonstrates the quantitative 
incorporation of phosphoserine with each SepRS (XX) /pSer tRNA(XX)CUA pair. The found mass was 
18407 Da for all samples, the calculated mass was 18407 Da). 
 




Supplementary Figure 5. ESI-MS from the expressions shown in Figure 3.  A.  Electrospray 
ionization mass spectrometry of Ni-NTA purified Myoglobin (127pSer)-His6 demonstrates the 
quantitative incorporation of phosphoserine with each SepRS /pSer tRNA(XX)CUA pair.  B.  Electrospray 
ionization mass spectrometry of Ni-NTA purified Myoglobin (127pSer)-His6 demonstrates the 
quantitative incorporation of phosphoserine with each SepRS(XX) /pSer tRNA(XX)CUA pair. The found 














Supplementary Figure 6.  An optimized system for phosphoserine incorporation in 
recombinant proteins.  A.  The ratios of GST-CaM to GST provide a measure of the efficiency 
of amber stop codon read through.  In gst(XXX)cam, XXX is varied to the codons  shown in the 
legend.  In TAG(1) the amber codon is decoded by the endogenous ribosome in DH10BΔserB.   
In TAG(2) the amber codon is decoded in C321ΔserB(DE3), in which RF-1 is deleted. In 
TAG(3) the amber codon is presented in an orthogonal message (o-gst(TAG)cam) that is 
decoded by an evolved orthogonal ribosome, ribo-Q1, that does not recognize RF-1.  B. ESI-
MS/MS of GST-CaM with site-specific incorporation of phosphoserine from the experiment 
shown in lane 5 of A. 
 














Supplementary Figure 7. Ub (pSer65) stimulates Parkin mediated ubiquitin discharge from 
loaded E2. An E2-discharge assay was performed by incubation of full-length (WT), Parkin in the 
presence or absence of 1 µg of Ub(pSer65), enzymatically derived Ub(pSer65*) or Ub with 2 µg of 
UbcH7 that had been pre-incubated with E1 and FLAG–ubiquitin in the presence of Mg2+-ATP for 60 
min. Reactions were allowed to continue for 10 min and were stopped using LDS loading buffer in the 
absence of reducing agent. The reaction products were resolved by SDS/PAGE and the proteins were 



























Supplementary Figure 9.  Autophosphorylation of Nek7. A. Nek7(pSer195)-His6 
phosphorylates itself. Autophosphorylation of NEK7 is consistent with the mass observed for the 
minor peak in Electrospray ionization mass spectrometry of purified Nek7(pSer195)-His6 (Shown 
in Figure 5b). B. Scintillation-count quantification of autophosphorylation shown in panel A. 
The data represent the mean of three independent trials and the error bars represent the s.d. 
 




Supplementary Figure 10. The site-specific incorporation of phosphoserine into a kinase 
dead variant (D179N) of the essential human kinase Nek7 to yield homogenously 
phosphorylated protein. A. Anti-His western blot of whole cell lysate of Nek7(D179N)-His6 
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expressed from a single plasmid system compared with Nek7(D179N-pSer195)-His6  expressed 
from a two plasmid system.  The purified yield of full-length phosphorylated protein is 2.1mg/L 
and is comparable to the yield of non-phosphorylated protein. B. Electrospray ionization mass 
spectrometry of purified Nek7(D179N-pSer195)-His6  demonstrates the quantitative incorporation 
of phosphoserine. A representative de-convoluted MS is shown along with the raw spectra. C.  
Representative MS/MS trace of Nek7(D179N-pSer195)-His6 confirms phosphoserine 










Supplementary Figure 11.  Kinase assay demonstrating constitutive activity of 
Nek7(pSer195)-His6 compared to wild type Nek7 with myelin basic protein (MBP) as 
substrate. Addition of the activating GST-Nek9-CTD protein fragment results in no additional 
Nek7 activity, indicating that Nek7-S195 phosphorylation alone is sufficient to fully activate the 
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